Androgenetic Alopecia

Dermatology
3
Pipeline Programs
3
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
1
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

BT
3 programs
2
1
Topical SM04554 solutionPhase 2/31 trial
SM04554Phase 21 trial
Topical SM04554 solutionPhase 21 trial
Active Trials
NCT02275351CompletedEst. Nov 2015
NCT02503137CompletedEst. Apr 2016
NCT03742518CompletedEst. Dec 2020
Kimia Therapeutics
Kimia TherapeuticsCA - Berkeley
1 program
Minoxidil TopicalN/A1 trial
Active Trials
NCT06066827UnknownEst. Nov 2023
Catalyst Pharmaceuticals
Catalyst PharmaceuticalsCORAL GABLES, FL
1 program
REVIAN 101N/A1 trial
Active Trials
NCT04019795CompletedEst. May 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Biosplice TherapeuticsTopical SM04554 solution
Biosplice TherapeuticsTopical SM04554 solution
Biosplice TherapeuticsSM04554
Kimia TherapeuticsMinoxidil Topical
Catalyst PharmaceuticalsREVIAN 101

Clinical Trials (5)

NCT03742518Biosplice TherapeuticsTopical SM04554 solution

A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia

Start: Nov 2018Est. completion: Dec 2020
Phase 2/3Completed
NCT02503137Biosplice TherapeuticsTopical SM04554 solution

A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing

Start: Aug 2015Est. completion: Apr 2016
Phase 2Completed
NCT02275351Biosplice TherapeuticsSM04554

A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)

Start: Nov 2014Est. completion: Nov 2015
Phase 2Completed
NCT06066827Kimia TherapeuticsMinoxidil Topical

Hair Regeneration in Androgenetic Alopecia

Start: Aug 2023Est. completion: Nov 2023
N/AUnknown
NCT04019795Catalyst PharmaceuticalsREVIAN 101

Modulated Light Therapy in Participants With Pattern Hair Loss

Start: Jan 2017Est. completion: May 2019
N/ACompleted

Related Jobs in Dermatology

MSL/Senior MSL, Dermatology - Tampa, Florida

AbbVie
Remote
6h ago

(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen

AbbVie
Remote
6h ago

(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen

AbbVie
Remote
6h ago

Regional Sales Trainer - Dermatology (Central / West Regions)

AbbVie
Remote
7h ago

Regional Sales Trainer - Dermatology (Northeast / Southeast Regions)

AbbVie
Remote
7h ago

Delegado Especialista Ventas Dermatología (Inmunología)

AbbVie
Remote
11h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

Related Indications

Dermatitis, Atopic(42)Hidradenitis Suppurativa(30)Chronic Spontaneous Urticaria(21)Alopecia Areata(17)Hidradenitis Suppurativa (HS)(10)Vitiligo(9)Rosacea(6)Chronic Urticaria(5)Pruritus(5)Uremic Pruritus(5)